Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 8/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | FNTA | P49354 | 7/20 | 0.50 |
| ▸ | FNTB | P49356 | 7/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9729596 | 0.89 | TACR1 (0.80) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729430 | 0.89 | TACR1 (0.80) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9730162 | 0.85 | TACR1 (0.62) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729234 | 0.84 | TACR1 (0.61) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729210 | 0.84 | TACR1 (0.66) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729456 | 0.83 | TACR1 (0.59) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9372683 | 0.83 | TACR1 (0.72) | TACR1MEN1KMT2ACYP3A4MAPT | |
| Hydrochloric Acid SCHEMBL9729558 | 0.82 | TACR1 (0.71) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729985 | 0.82 | TACR1 (0.58) | TACR1MEN1KMT2ACYP3A4MAPT | |
| SCHEMBL9729329 | 0.82 | TACR1 (0.58) | TACR1MEN1KMT2ACYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5102667-A | Antiallergens, antiinflammatory agents, nervous system disorders, immunology, psychological disorders | RHONE-POULENC SANTE (FR) | 1992-04-07 | — | — | US | disclosed |